NRx Pharmaceuticals (NRXP) Insider Trading & Ownership $1.21 -0.02 (-1.63%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NRx Pharmaceuticals (NASDAQ:NRXP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage19.00%Number OfInsiders Buying(Last 3 Years)6Amount OfInsider Buying(Last 3 Years)$6.32 MNumber OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$1.54 M Get NRXP Insider Trade Alerts Want to know when executives and insiders are buying or selling NRx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address NRXP Insider Buying and Selling by Quarter Ad Wide Moat ResearchTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. NRx Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/30/2023Aaron GorovitzDirectorBuy3,500$3.20$11,200.00 8/22/2023Jonathan C JavittInsiderBuy20,000$3.20$64,000.00 12/16/2022Stephen H WillardCEOBuy5,000$11.70$58,500.00 12/16/2022Voorhees Seth VanCFOBuy3,000$11.00$33,000.00 12/7/2022Jonathan C JavittDirectorSell40,000$10.00$400,000.00 11/29/2022Daniel C JavittMajor ShareholderSell1,373$15.00$20,595.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/28/2022Patrick John FlynnDirectorBuy175$12.50$2,187.50 11/25/2022Voorhees Seth VanCFOBuy1,633$11.10$18,126.30 11/18/2022Chaim HurvitzDirectorBuy4,040$11.00$44,440.00 11/17/2022Daniel C JavittMajor ShareholderSell3,301$10.50$34,660.50 11/16/2022Chaim HurvitzDirectorBuy28,781$9.90$284,931.90 11/11/2022Daniel C JavittMajor ShareholderSell4,920$10.10$49,692.00 7/29/2022Daniel C JavittMajor ShareholderSell7,840$101.00$791,840.00 6/6/2022Daniel C JavittMajor ShareholderSell1,156$67.00$77,452.00 6/3/2022Daniel C JavittMajor ShareholderSell2,435$70.00$170,450.00 6/1/2022Jonathan C JavittInsiderBuy1,000$5,800.00$5,800,000.00 (Data available from 1/1/2013 forward) NRXP Insider Trading Activity - Frequently Asked Questions Who is on NRx Pharmaceuticals's Insider Roster? The list of insiders at NRx Pharmaceuticals includes Aaron Gorovitz, Chaim Hurvitz, Daniel C Javitt, Jonathan C Javitt, Patrick John Flynn, Stephen H Willard, and Voorhees Seth Van. Learn more on insiders at NRXP. What percentage of NRx Pharmaceuticals stock is owned by insiders? 19.00% of NRx Pharmaceuticals stock is owned by insiders. Learn more on NRXP's insider holdings. Which NRx Pharmaceuticals insiders have been buying company stock? The following insiders have purchased NRXP shares in the last 24 months: Aaron Gorovitz ($11,200.00), Jonathan C Javitt ($64,000.00), Patrick John Flynn ($2,187.50), Stephen H Willard ($58,500.00), and Voorhees Seth Van ($51,126.30). How much insider buying is happening at NRx Pharmaceuticals? Insiders have purchased a total of 33,308 NRXP shares in the last 24 months for a total of $187,013.80 bought. Which NRx Pharmaceuticals insiders have been selling company stock? The following insiders have sold NRXP shares in the last 24 months: Daniel C Javitt ($20,595.00), and Jonathan C Javitt ($400,000.00). How much insider selling is happening at NRx Pharmaceuticals? Insiders have sold a total of 41,373 NRx Pharmaceuticals shares in the last 24 months for a total of $420,595.00 sold. NRx Pharmaceuticals Key ExecutivesDr. Jonathan C. Javitt M.D. (Age 67)M.P.H., Co-Founder, Chief Scientist Officer & Chairman Compensation: $630.2kMr. Stephen H. Willard Esq. (Age 63)Acting Corporate Secretary, CEO & Director Compensation: $500kMr. Richard Clavano Narido (Age 45)CFO & Treasurer Compensation: $255.01kDr. Riccardo Panicucci Ph.D. (Age 63)Chief Manufacturing & Technology Officer Compensation: $240kSuzanne MessereInvestor RelationsDr. Philip T. Lavin Ph.D. (Age 77)Chief Methodologist Mr. Matthew Patrick Duffy (Age 61)Chief Business Officer More Insider Trading Tools from MarketBeat Related Companies MNTS Insider Transactions ENTX Insider Transactions MURA Insider Transactions IOBT Insider Transactions DTIL Insider Transactions AADI Insider Transactions STTK Insider Transactions KZR Insider Transactions PRLD Insider Transactions VOR Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:NRXP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRXP Stock Alerts